Parameters | Assessment point | Status of priming | HIV-1 positive | HIV negative | Community controls | ||||
Fe pos (Sgr I) n = 54 | Fe neg (Sgr II) n = 54 | Fe pos (Sgr III) | Fe neg (Sgr IV) | (Sgr V) | |||||
Category of ARI on follow up | Category of ARI on follow up |
|
|
| |||||
PT n = 38 | non-PT n = 16 | PT n = 10 | non-PT n = 44 | n = 30 | n = 50 | n = 40 | |||
Nitrite (nmol/well) | En | Unpr | 0.31 ± 0.20‽‡ | 0.62 ± 0.32‽ | 8.2 ± 2.4# | 5.1 ± 2.6# | 0.39 ± 0.24‽ | 3.1 ± 0.8 | 2.8 ± 0.6 |
Pr | 0.32 ± 0.26 | 0.58 ± 0.32 | 14.8 ± 4.2† | 12.6 ± 4.8† | 0.42 ± 0.36 | 10.2 ± 4.8† | 8.4 ± 2.6† | ||
Fu | Unpr | 18.2 ± 2.4#§* | 9.1 ± 1.9#* | 10.6 ± 2.8# | 6.8 ± 3.6# | NA | NA | NA | |
Pr | 42.8 ± 8.2§ | 22.2 ± 3.2†* | 28.2 ± 5.6†* | 26.2 ± 4.6†* | NA | NA | NA | ||
Superoxide (nmol/mg protein/ min) | En | Unpr | 17.2 ± 4.1#§ | 9.6 ± 2.4# | 6.8 ± 3.2 | 5.8 ± 3.4 | 14.1 ± 9.6# | 4.6 ± 1.6 | 4.1 ± 1.8 |
Pr | 18.6 ± 3.2§ | 10.2 ± 4.2 | 12.6 ± 4.2† | 16.2 ± 4.1† | 16.6 ± 7.2 | 6.3 ± 2.6 | 5.2 ± 1.2† | ||
Fu | Unpr | 21.4 ± 2.6# | 17.4 ± 3.8#* | 7.2 ± 3.8# | 6.2 ± 3.6 | NA | NA | NA | |
Pr | 48 ± 8.4†* | 42 ± 8.2†* | 24.6 ± 4.6†* | 26.2 ± 6.2†* | NA | NA | NA |